Sign Up to like & get
recommendations!
0
Published in 2021 at "Journal of hepatology"
DOI: 10.1016/j.jhep.2021.10.026
Abstract: BACKGROUND & AIMS Children and adults with lysosomal acid lipase deficiency (LAL-D) experience cirrhosis and dyslipidemia from lysosomal accumulation of cholesteryl esters and triglycerides. Sebelipase alfa enzyme replacement therapy is indicated for individuals with LAL-D.…
read more here.
Keywords:
open label;
sebelipase alfa;
lysosomal acid;
alfa ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2019 at "Molecular Genetics and Metabolism Reports"
DOI: 10.1016/j.ymgmr.2019.100479
Abstract: We report on a case of very rare autosomal recessive cholesteryl ester storage disease due to lysosomal acid lipase deficiency (LALD). LALD is caused by mutations in the lysosomal acid lipase A (LIPA) gene resulting…
read more here.
Keywords:
acid lipase;
lysosomal acid;
sebelipase alfa;
patient ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2022 at "Journal of pediatric gastroenterology and nutrition"
DOI: 10.1097/mpg.0000000000003452
Abstract: OBJECTIVES Sebelipase alfa is approved for treatment of lysosomal acid lipase deficiency (LAL-D). This single-arm, open-label study (NCT02112994) evaluated sebelipase alfa efficacy and safety in patients with LAL-D. METHODS Patients >8 months of age diagnosed with…
read more here.
Keywords:
treatment;
sebelipase alfa;
acid lipase;
lysosomal acid ... See more keywords